Literature DB >> 22652598

Genetic ablation of Adamts13 gene dramatically accelerates the formation of early atherosclerosis in a murine model.

Sheng-Yu Jin1, Junichiro Tohyama, Robert C Bauer, Na Nora Cao, Daniel J Rader, X Long Zheng.   

Abstract

OBJECTIVE: ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats-13) cleaves von Willebrand factor, thereby modulating thrombosis and inflammation. Low plasma ADAMTS13 activity is associated with cardiovascular events, including myocardial and cerebral infarction. Here, we investigated the role of ADAMTS13 in the development of early atherosclerosis in a murine model. METHODS AND
RESULTS: Apolipoprotein E-null (ApoE(-/-)) and Adamts13-null (Adamts13(-/-)) ApoE(-/-) mice were fed with a high-fat Western diet for 12 weeks. Atherosclerotic lesions in the aorta and aortic roots were quantified after staining. Leukocyte rolling and adhesion onto cremaster venules after oxidative injury were determined by intravital microscopy. Although plasma cholesterol levels were largely similar in both groups, the extent of atherosclerotic lesions in the aorta en face and in the aortic roots in the Adamts13(-/-)ApoE(-/-) mice increased ≈ 5.5-fold (P=0.0017) and ≈ 6.1-fold (P=0.0037), respectively. In addition, the ratio of plasma high- to low-molecular-weight von Willebrand factor multimers increased ≈ 3-fold. The leukocyte rolling velocities were significantly reduced (P<0.001), with an increased number of leukocyte rolling (P=0.0026) and macrophage infiltration into the atherosclerotic lesions in the Adamts13(-/-)ApoE(-/-) mice.
CONCLUSIONS: Our results suggest that ADAMTS13 plays a critical role in modulating the development of early atherosclerosis, likely through the proteolytic cleavage of ultra-large von Willebrand factor multimers, thereby inhibiting platelet deposition and inflammation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22652598      PMCID: PMC3422623          DOI: 10.1161/ATVBAHA.112.247262

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  36 in total

Review 1.  Thrombotic microangiopathies.

Authors:  Joel L Moake
Journal:  N Engl J Med       Date:  2002-08-22       Impact factor: 91.245

2.  ADAMTS-13 metalloprotease interacts with the endothelial cell-derived ultra-large von Willebrand factor.

Authors:  Jing-fei Dong; Joel L Moake; Aubrey Bernardo; Kazuo Fujikawa; Chalmette Ball; Leticia Nolasco; José A López; Miguel A Cruz
Journal:  J Biol Chem       Date:  2003-05-29       Impact factor: 5.157

3.  Leukocyte-endothelial cell recognition: evidence of a common molecular mechanism shared by neutrophils, lymphocytes, and other leukocytes.

Authors:  D M Lewinsohn; R F Bargatze; E C Butcher
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

4.  Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura.

Authors:  X Zheng; D Chung; T K Takayama; E M Majerus; J E Sadler; K Fujikawa
Journal:  J Biol Chem       Date:  2001-09-13       Impact factor: 5.157

5.  Localized reduction of atherosclerosis in von Willebrand factor-deficient mice.

Authors:  N Methia; P André; C V Denis; M Economopoulos; D D Wagner
Journal:  Blood       Date:  2001-09-01       Impact factor: 22.113

6.  ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions.

Authors:  Jing-fei Dong; Joel L Moake; Leticia Nolasco; Aubrey Bernardo; Wendy Arceneaux; Corie N Shrimpton; Alicia J Schade; Larry V McIntire; Kazuo Fujikawa; José A López
Journal:  Blood       Date:  2002-07-25       Impact factor: 22.113

7.  Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab.

Authors:  Xinglong Zheng; Arnel M Pallera; Lawrence T Goodnough; J Evan Sadler; Morey A Blinder
Journal:  Ann Intern Med       Date:  2003-01-21       Impact factor: 25.391

8.  A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation.

Authors:  Steffen Massberg; Korbinian Brand; Sabine Grüner; Sharon Page; Elke Müller; Iris Müller; Wolfgang Bergmeier; Thomas Richter; Michael Lorenz; Ildiko Konrad; Bernhard Nieswandt; Meinrad Gawaz
Journal:  J Exp Med       Date:  2002-10-07       Impact factor: 14.307

9.  Biosynthesis of von Willebrand protein by human endothelial cells: processing steps and their intracellular localization.

Authors:  D D Wagner; V J Marder
Journal:  J Cell Biol       Date:  1984-12       Impact factor: 10.539

10.  P-selectin glycoprotein ligand-1 mediates L-selectin-dependent leukocyte rolling in venules.

Authors:  Markus Sperandio; Michael L Smith; S Bradley Forlow; Timothy S Olson; Lijun Xia; Rodger P McEver; Klaus Ley
Journal:  J Exp Med       Date:  2003-05-19       Impact factor: 14.307

View more
  24 in total

1.  Molecular Imaging of Platelet-Endothelial Interactions and Endothelial von Willebrand Factor in Early and Mid-Stage Atherosclerosis.

Authors:  Chi Young Shim; Ya Ni Liu; Tamara Atkinson; Aris Xie; Ted Foster; Brian P Davidson; Mackenzie Treible; Yue Qi; José A López; Adam Munday; Zaverio Ruggeri; Jonathan R Lindner
Journal:  Circ Cardiovasc Imaging       Date:  2015-07       Impact factor: 7.792

2.  Endothelial expression of guidance cues in vessel wall homeostasis dysregulation under proatherosclerotic conditions.

Authors:  Janine M van Gils; Bhama Ramkhelawon; Luciana Fernandes; Merran C Stewart; Liang Guo; Tara Seibert; Gustavo B Menezes; Denise C Cara; Camille Chow; T Bernard Kinane; Edward A Fisher; Mercedes Balcells; Jacqueline Alvarez-Leite; Adam Lacy-Hulbert; Kathryn J Moore
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02-21       Impact factor: 8.311

Review 3.  Platelets and von Willebrand factor in atherogenesis.

Authors:  Melinda D Wu; Tamara M Atkinson; Jonathan R Lindner
Journal:  Blood       Date:  2017-02-07       Impact factor: 22.113

Review 4.  Structure-function and regulation of ADAMTS-13 protease.

Authors:  X L Zheng
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

Review 5.  ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura.

Authors:  X Long Zheng
Journal:  Annu Rev Med       Date:  2015       Impact factor: 13.739

6.  Unconjugated bilirubin inhibits proteolytic cleavage of von Willebrand factor by ADAMTS13 protease.

Authors:  R-N Lu; S Yang; H M Wu; X L Zheng
Journal:  J Thromb Haemost       Date:  2015-04-23       Impact factor: 5.824

7.  Reduced ADAMTS13 activity during TTP remission is associated with stroke in TTP survivors.

Authors:  Harshvardhan Upreti; Jamil Kasmani; Kathryn Dane; Evan M Braunstein; Michael B Streiff; Satish Shanbhag; Alison R Moliterno; C John Sperati; Rebecca F Gottesman; Robert A Brodsky; Thomas S Kickler; Shruti Chaturvedi
Journal:  Blood       Date:  2019-08-20       Impact factor: 22.113

8.  Human neutrophil peptides inhibit cleavage of von Willebrand factor by ADAMTS13: a potential link of inflammation to TTP.

Authors:  Vikram G Pillai; Jialing Bao; Catherine B Zander; Jenny K McDaniel; Palaniappan S Chetty; Steven H Seeholzer; Khalil Bdeir; Douglas B Cines; X Long Zheng
Journal:  Blood       Date:  2016-05-13       Impact factor: 22.113

9.  ADAMTS13 deficiency exacerbates VWF-dependent acute myocardial ischemia/reperfusion injury in mice.

Authors:  Chintan Gandhi; David G Motto; Melissa Jensen; Steven R Lentz; Anil K Chauhan
Journal:  Blood       Date:  2012-09-14       Impact factor: 22.113

10.  Endothelial Cell-Derived Von Willebrand Factor, But Not Platelet-Derived, Promotes Atherosclerosis in Apolipoprotein E-Deficient Mice.

Authors:  Prakash Doddapattar; Nirav Dhanesha; Mehul R Chorawala; Chandler Tinsman; Manish Jain; Manasa K Nayak; Janice M Staber; Anil K Chauhan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-01-18       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.